ERC Starting Grant PriME
The project maps oxidative modifications to proteins and associates them with functions. The aim is to use various plasma processes to achieve a molecular change in the proteins of colon cancer cells, making them more visible to the immune system. The vision is to use this approach to break new ground in therapeutic vaccination in colon cancer patients using plasma technology.
